Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 1.00 |
| ▸ | HTR1A | P08908 | 8/20 | 1.00 |
| ▸ | HTR2C | P28335 | 7/20 | 1.00 |
| ▸ | HTR2B | P41595 | 5/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.81 |
| ▸ | HTR6 | P50406 | 6/20 | 0.76 |
| ▸ | HTR1B | P28222 | 4/20 | 0.76 |
| ▸ | HTR7 | P34969 | 3/20 | 0.76 |
| ▸ | HTR5A | P47898 | 2/20 | 0.76 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.76 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.76 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.76 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.76 |
| ▸ | HRH1 | P35367 | 2/20 | 0.76 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.76 |
| ▸ | MAOA | P21397 | 1/20 | 0.76 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.76 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.76 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N,N-Dimethyltryptamine SCHEMBL29350959 | 1.00 | HTR2A (1.00) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL27221709 | 1.00 | HTR2A (1.00) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL23069121 | 0.98 | HTR2A (0.97) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL25285129 | 0.98 | HTR2A (0.97) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL27657713 | 0.91 | HTR1A (0.82) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| SCHEMBL3957606 | 0.90 | SLC6A4 (1.00) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| SCHEMBL30896267 | 0.89 | HTR2A (0.81) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL25256369 | 0.88 | HTR2A (0.79) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL31289392 | 0.88 | HTR1A (0.78) | HTR2AHTR1AHTR2CHTR2BSLC6A4 | |
| N,N-Dimethyltryptamine SCHEMBL30785193 | 0.88 | HTR1A (0.78) | HTR2AHTR1AHTR2CHTR2BSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3420 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144807-A1 | METHOD OF ADMINISTRATION OF A PARENTERAL FORMULATION COMPRISING A PSYCHEDELIC AGENT | CYBIN UK LTD (GB) | 2026-05-28 | — | — | US | claimed |
| US-12616706-B2 | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations | Arbormentis LLC (US) | 2026-05-05 | — | — | US | claimed |
| US-20260116853-A1 | NEW N,N-DIMETHYLTRYPTAMINE SALTS AND CRYSTALLINE SALT FORMS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4728531-A1 | BIOADAPTIVE THERAPEUTIC ENVIRONMENTS | Therapod LLC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12595497-B2 | Processes for the production of tryptamines | COMPASS PATHFINDER LIMITED (GB) | 2026-04-07 | — | — | US | claimed |
| US-20260090584-A1 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | DRESDNER JR KARL P (US) | 2026-04-02 | — | — | US | claimed |
| US-20260083759-A1 | Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders | HADASIT MED RES SERVICE (IL) | 2026-03-26 | — | — | US | claimed |
| US-20260080800-A1 | COMBINATION THERAPY WITH DIGITAL THERAPEUTICS FOR IMPROVED IMMUNE FUNCTION | REMEPY HEALTH LTD (IL) | 2026-03-19 | — | — | US | claimed |
| EP-4704826-A1 | COMPOSITIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER | Yale University (US) | 2026-03-11 | — | — | EP | claimed |
| EP-1319070-A2 | MAMMALIAN RECEPTOR GENES AND USES | Oregon Health & Science University (US) | 2003-06-18 | — | — | EP | claimed |
| US-20030082802-A1 | Preparing culture of nervous system tissues; prepare nutrient broth containing agonist, inoculate with nervous system stem cells, propagate and recover cells | PSYCHIATRIC GENOMICS, INC. (US) | 2003-05-01 | — | — | US | claimed |
| US-20030078231-A1 | Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties | WILBURN MICHAEL D (US) | 2003-04-24 | — | — | US | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
| WO-2002102988-A2 | METHOD FOR NEURAL STEM CELL DIFFERENTIATION USING 5HT-1A AGONISTS | PSYCHIATRIC GENOMICS, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| WO-2002022801-A2 | MAMMALIAN RECEPTOR GENES AND USES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2002-03-21 | — | — | WO | claimed |
| EP-0251938-B1 | STEREOSPECIFIC PROCESS FOR THE SYNTHESIS OF INDOLE DERIVATIVES | SANOFI (FR) | 1991-11-06 | — | — | EP | claimed |
| EP-0251938-A1 | Stereospecific process for the synthesis of indole derivatives | SANOFI (FR) | 1988-01-07 | — | — | EP | claimed |
| US-4620977-A | Treatment methods, particularly for psychoactive drug dependence | STRAHILEVITZ MEIR | 1986-11-04 | — | — | US | claimed |
| US-4375414-A | Immunological methods for removing species from the blood circulatory system and devices therefor | STRAHILEVITZ MEIR | 1983-03-01 | — | — | US | claimed |